- Home
- HEPA vs MULN Comparison
HEPA vs MULN Comparison
Compare HEPA & MULN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HEPA
- MULN
- Stock Information
- Founded
- HEPA 2013
- MULN 2014
- Country
- HEPA United States
- MULN United States
- Employees
- HEPA N/A
- MULN N/A
- Industry
- HEPA Biotechnology: Pharmaceutical Preparations
- MULN Auto Manufacturing
- Sector
- HEPA Health Care
- MULN Consumer Discretionary
- Exchange
- HEPA Nasdaq
- MULN Nasdaq
- Market Cap
- HEPA 4.7M
- MULN 4.1M
- IPO Year
- HEPA N/A
- MULN N/A
- Fundamental
- Price
- HEPA $0.68
- MULN $2.54
- Analyst Decision
- HEPA Hold
- MULN
- Analyst Count
- HEPA 1
- MULN 0
- Target Price
- HEPA N/A
- MULN N/A
- AVG Volume (30 Days)
- HEPA 39.0K
- MULN 5.6M
- Earning Date
- HEPA 11-26-2024
- MULN 08-12-2024
- Dividend Yield
- HEPA N/A
- MULN N/A
- EPS Growth
- HEPA N/A
- MULN N/A
- EPS
- HEPA N/A
- MULN N/A
- Revenue
- HEPA N/A
- MULN $156,570.00
- Revenue This Year
- HEPA N/A
- MULN N/A
- Revenue Next Year
- HEPA N/A
- MULN N/A
- P/E Ratio
- HEPA N/A
- MULN N/A
- Revenue Growth
- HEPA N/A
- MULN N/A
- 52 Week Low
- HEPA $0.55
- MULN $1.60
- 52 Week High
- HEPA $4.47
- MULN $2,100.00
- Technical
- Relative Strength Index (RSI)
- HEPA 52.88
- MULN 37.23
- Support Level
- HEPA $0.60
- MULN $1.60
- Resistance Level
- HEPA $0.68
- MULN $3.68
- Average True Range (ATR)
- HEPA 0.05
- MULN 0.47
- MACD
- HEPA 0.00
- MULN 0.72
- Stochastic Oscillator
- HEPA 87.80
- MULN 45.19
About HEPA Hepion Pharmaceuticals Inc.
Hepion Pharmaceuticals Inc is a biopharmaceutical company that focuses primarily on the development of drug therapy for the treatment of chronic liver diseases. This therapeutic approach targets fibrosis and hepatocellular carcinoma associated with non-alcoholic steatohepatitis, viral hepatitis, and other liver diseases. Its cyclophilin inhibitor, Rencofilstat, is being developed to offer benefits to address these multiple complex pathologies. Rencofilstat is a pan-cyclophilin inhibitor that targets multiple pathologic pathways involved in the progression of liver disease.
About MULN Mullen Automotive Inc.
Mullen Automotive Inc is engaged in manufacturing electric vehicles and energy solutions. The company strives to make electric vehicles more accessible by building an end-to-end ecosystem that takes care of all aspects of electric vehicle ownership. The Company owns and partners with several synergistic businesses, all working towards the same goal of creating clean and scalable electric vehicles and energy solutions. The company has two segments Bollinger and Mullen/ELMS, which generates revenue.